Staff Members - Benha University
Forkhead Box P3 (FOXP3) Gene Polymorphisms Association with Its Serum Levels in Egyptian Vitiligo Patients
the Egyptian Journal of Hospital Medicine • 2022
Publication Information
Authors
Aliaa E. M. Daifalla¹, Hanan A. Abd El-Mohsen², Mahmoud A. Sabour², Reem R. Abd El-Galil², Amal M. Matta²
Keywords
Not Available
Journal
the Egyptian Journal of Hospital Medicine
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Vitiligo is an autoimmune disorder characterized by loss of pigmentation from the skin due to selective destruction of cutaneous melanocytes. Its pathogenesis is linked to regulatory T-cell (Treg) dysfunction. Forkhead box P3 (FOXP3) is a specific Treg marker and a master regulator of its activity.
Objective: The purpose of this study was to examine the relationship between serum levels of FOXP3 in Egyptian vitiligo patients and single-nucleotide polymorphisms (SNPs) at two distinct loci (rs3761548) A/C and (rs2232365) A/G situated in the promoter region of the FOXP3 gene.
Patients and methods: The study comprised 50 untreated vitiligo patients who attended the dermatology clinic at Benha University Hospitals, and 30 age- and sex-matched healthy controls. Polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) was used to identify FOXP3 gene polymorphism, and a FOXP3 enzyme linked immunosorbent assay (ELISA) was used to assess the quantity of FOXP3 in the blood.
Results: Highly significant difference (P
Objective: The purpose of this study was to examine the relationship between serum levels of FOXP3 in Egyptian vitiligo patients and single-nucleotide polymorphisms (SNPs) at two distinct loci (rs3761548) A/C and (rs2232365) A/G situated in the promoter region of the FOXP3 gene.
Patients and methods: The study comprised 50 untreated vitiligo patients who attended the dermatology clinic at Benha University Hospitals, and 30 age- and sex-matched healthy controls. Polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) was used to identify FOXP3 gene polymorphism, and a FOXP3 enzyme linked immunosorbent assay (ELISA) was used to assess the quantity of FOXP3 in the blood.
Results: Highly significant difference (P